Xu Zhenyu
Chief Scientific Officer
Xu Zhenyu has filed 21 SEC Form 4 filings (31 transaction rows) across 1 company, with disclosures dating back to 2026. 21 of those filings fall inside the rolling window. Most recent filing: Oct 14, 2026.
On the most recent filing, Xu Zhenyu is listed as Chief Scientific Officer at SOPHiA GENETICS SA. Inside the rolling window, Xu Zhenyu reported no open-market purchases and 25 open-market sales totaling $814K in SOPH. The largest disclosed transaction in the window is a sale of 17,000 SOPH shares on Aug 7, 2026, worth $124K.
Companies traded
Other insiders at SOPH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$814K
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| SOPH | Chief Scientific Officer | Sale | 4,000 | $29K | Oct 14 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 7,394 | $60K | Oct 7 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 4,000 | $32K | Sep 16 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 10,000 | $89K | Aug 31 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 10,000 | $79K | Aug 21 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 4,592 | $39K | Aug 21 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 5,408 | $45K | Aug 21 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 4,000 | $30K | Aug 14 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 3,000 | $21K | Aug 7 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 17,000 | $124K | Aug 7 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 10,000 | $69K | Aug 5 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 4,000 | $23K | Jul 14 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 7,393 | $38K | Jul 7 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 4,000 | $20K | Jun 17 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 608 | $3K | May 20 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 4,000 | $18K | May 14 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 608 | $3K | Apr 21 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 600 | $3K | Apr 16 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 3,706 | $17K | Apr 14 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 4,414 | $21K | Apr 14 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 2,800 | $14K | Apr 10 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 1,936 | $9K | Apr 10 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 2,700 | $13K | Apr 8 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 2,400 | $12K | Apr 8 | SEC ↗ | |
| SOPH | Chief Scientific Officer | Sale | 608 | $3K | Mar 20 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Xu Zhenyu made?
Xu Zhenyu has filed 21 SEC Form 4 filings (31 transaction rows) across 1 company since 2026.
Which companies does Xu Zhenyu trade?
Xu Zhenyu has filed SEC Form 4 disclosures for 1 company, including SOPH.
When was Xu Zhenyu's most recent SEC Form 4 filing?
Xu Zhenyu's most recent SEC Form 4 filing on Tracefour is dated Oct 14, 2026.
What is Xu Zhenyu's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Xu Zhenyu is listed as Chief Scientific Officer.
What is Xu Zhenyu's total buy and sell value in the current window?
Inside the rolling retention window, Xu Zhenyu bought $0 and sold $814K based on SEC Form 4 filings.
What was Xu Zhenyu's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 17,000 SOPH shares on 2026-08-07, worth $124K, per SEC Form 4 filings.